Plandaí Biotechnology, Inc. (PLPL)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
Apr 22, 2025, 4:00 PM EDT
Plandaí Biotechnology Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '16 Sep 30, 2016 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 | Jun '13 Jun 30, 2013 | Jun '12 Jun 30, 2012 | 2011 |
| Operating Revenue | 0.23 | 0.19 | 0.01 | 0.27 | 0.36 | 0.07 | Upgrade
|
| Other Revenue | 0.1 | 0.1 | 0.09 | - | - | - | Upgrade
|
| Revenue | 0.34 | 0.3 | 0.09 | 0.27 | 0.36 | 0.07 | Upgrade
|
| Revenue Growth (YoY) | 215.33% | 221.31% | -65.04% | -26.01% | 382.38% | - | Upgrade
|
| Cost of Revenue | 0.91 | 0.94 | 0.79 | 0.95 | 0.96 | - | Upgrade
|
| Gross Profit | -0.57 | -0.64 | -0.69 | -0.69 | -0.6 | 0.07 | Upgrade
|
| Selling, General & Admin | 1.87 | 1.94 | 7.74 | 3.87 | 1.92 | 3.88 | Upgrade
|
| Operating Expenses | 2.38 | 2.46 | 8.16 | 4.06 | 2.05 | 3.88 | Upgrade
|
| Operating Income | -2.95 | -3.11 | -8.85 | -4.74 | -2.66 | -3.81 | Upgrade
|
| Interest Expense | -1.97 | -1.79 | -0.93 | -1.03 | -0.31 | -0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.02 | -0.12 | -0 | -4.24 | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -4.93 | -5.01 | -9.78 | -10.01 | -2.97 | -3.84 | Upgrade
|
| Asset Writedown | - | - | - | -5.75 | - | - | Upgrade
|
| Other Unusual Items | 0.27 | 0.27 | -0.3 | -0.28 | - | - | Upgrade
|
| Pretax Income | -4.66 | -4.74 | -10.07 | -16.05 | -2.97 | -3.84 | Upgrade
|
| Earnings From Continuing Operations | -4.66 | -4.74 | -10.07 | -16.05 | -2.97 | -3.84 | Upgrade
|
| Minority Interest in Earnings | 0.34 | 0.36 | 0.49 | 0.44 | 0.78 | 0.06 | Upgrade
|
| Net Income | -4.32 | -4.38 | -9.58 | -15.61 | -2.19 | -3.78 | Upgrade
|
| Net Income to Common | -4.32 | -4.38 | -9.58 | -15.61 | -2.19 | -3.78 | Upgrade
|
| Shares Outstanding (Basic) | 196 | 174 | 137 | 115 | 111 | 96 | Upgrade
|
| Shares Outstanding (Diluted) | 196 | 174 | 137 | 115 | 111 | 96 | Upgrade
|
| Shares Change (YoY) | 35.33% | 27.17% | 19.33% | 3.45% | 15.13% | 26.74% | Upgrade
|
| EPS (Basic) | -0.02 | -0.03 | -0.07 | -0.14 | -0.02 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.03 | -0.07 | -0.14 | -0.02 | -0.04 | Upgrade
|
| Free Cash Flow | -1 | -1.08 | -3.56 | -3.32 | -3.81 | -6.83 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.03 | -0.03 | -0.07 | Upgrade
|
| Gross Margin | -168.10% | -215.98% | - | -257.95% | -168.20% | 100.00% | Upgrade
|
| Operating Margin | -871.19% | -1041.50% | -9526.11% | -1785.27% | -740.03% | -5117.09% | Upgrade
|
| Profit Margin | -1275.88% | -1467.07% | -10315.03% | -5873.14% | -609.23% | -5073.30% | Upgrade
|
| Free Cash Flow Margin | -295.30% | -362.92% | -3833.01% | -1249.98% | -1059.98% | -9168.49% | Upgrade
|
| EBITDA | -2.44 | -2.59 | -8.44 | -4.56 | -2.52 | -3.81 | Upgrade
|
| D&A For EBITDA | 0.51 | 0.52 | 0.41 | 0.19 | 0.14 | 0 | Upgrade
|
| EBIT | -2.95 | -3.11 | -8.85 | -4.74 | -2.66 | -3.81 | Upgrade
|
| Revenue as Reported | 0.3 | 0.3 | 0.09 | - | - | - | Upgrade
|
Updated Mar 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.